Takeda Pharmaceutical Company Ltd
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- -
- Established
- 1925-01-01
- Employees
- -
- Market Cap
- $47.5B
- Website
- http://www.takeda.co.jp/
Intravenous vs Oral Lansoprazole on Gastric Acid Secretion in Subjects With Erosive Esophagitis
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2010-07-21
- Lead Sponsor
- Takeda
- Target Recruit Count
- 68
- Registration Number
- NCT00175045
Efficacy of Pioglitazone on Macrovascular Outcome in Patients With Type 2 Diabetes
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2012-02-28
- Lead Sponsor
- Takeda
- Target Recruit Count
- 4373
- Registration Number
- NCT00174993
A Study to Evaluate the Effect of Lansoprazole on Hospitalized Neonates With Gastroesophageal Reflux Disease
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2010-07-22
- Lead Sponsor
- Takeda
- Target Recruit Count
- 24
- Registration Number
- NCT00174928
Validation Study of Physical Measurement of Tophi
Completed
- Conditions
- Gout
- Interventions
- Other: Measurement of Tophi to validate procedure
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2010-07-27
- Lead Sponsor
- Takeda
- Target Recruit Count
- 13
- Registration Number
- NCT00175006
Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-339)
Phase 3
Completed
- Conditions
- Gastroesophageal Reflux
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2012-05-07
- Lead Sponsor
- Takeda
- Target Recruit Count
- 1200
- Registration Number
- NCT00163306
- Locations
- 🇵🇱
Altana Pharma/Nycomed, Tychy, Poland
Efficacy & Safety of Resatorvid in Adults With Severe Sepsis
- First Posted Date
- 2005-09-02
- Last Posted Date
- 2012-02-02
- Lead Sponsor
- Takeda
- Target Recruit Count
- 277
- Registration Number
- NCT00143611
Efficacy of Lapaquistat Acetate and Atorvastatin on Blood Cholesterol Levels in Subjects With Primary Hypercholesterolemia
Phase 3
Completed
- Conditions
- Hypercholesterolemia
- Interventions
- First Posted Date
- 2005-09-02
- Last Posted Date
- 2012-05-24
- Lead Sponsor
- Takeda
- Target Recruit Count
- 448
- Registration Number
- NCT00143676
Effect of Lapaquistat Acetate on Blood Cholesterol Levels in Subjects With Elevated Cholesterol
- First Posted Date
- 2005-09-02
- Last Posted Date
- 2012-05-24
- Lead Sponsor
- Takeda
- Target Recruit Count
- 361
- Registration Number
- NCT00143663
Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.
- First Posted Date
- 2005-07-11
- Last Posted Date
- 2016-08-19
- Lead Sponsor
- Takeda
- Target Recruit Count
- 240
- Registration Number
- NCT00117884
Febuxostat Versus Allopurinol Control Trial in Subjects With Gout
- First Posted Date
- 2005-01-31
- Last Posted Date
- 2012-02-02
- Lead Sponsor
- Takeda
- Target Recruit Count
- 760
- Registration Number
- NCT00102440
© Copyright 2025. All Rights Reserved by MedPath